Table: begin end state 1 33 signal peptide 34 257 non-cytoplasmic 258 285 transmembrane 286 291 cytoplasmic 292 311 transmembrane 312 316 non-cytoplasmic 317 338 transmembrane 339 349 cytoplasmic 350 371 transmembrane 372 398 non-cytoplasmic 399 417 transmembrane 418 443 cytoplasmic 444 465 transmembrane 466 482 non-cytoplasmic 483 507 transmembrane 508 514 cytoplasmic 515 533 transmembrane 534 550 non-cytoplasmic
Input: >WP_011653192.1 NCBI__GCF_000009265.1:WP_011653192.1 MYRAIKIFLITVCLTFSGLVFSGFAFSGLTISSEVQAQDDIHVLIDALGVGDFPEREAAI KALVASKDPHVSQILQQLSDGLLYVNSDGGPVLLQGGTDDEPTYSDPITGEAVADVDPDL MTKVKINNALRGVIGAATSQLTLMSPDRSARLAAAQGLLKDADPANLDLLNTAIAAEKDA EIKNTMEAARAVLLLKTDASVEDKKAAIGTIAARGNRDALTILTTTLETAPDDLKPAIQA DISSINRSLALWDIVQNIWYGLSLGSVLLLAAIGLAITFGVMGVINMAHGEMVMIGAYTT YVVQEYITSAFPELADYSLAFAVPAAFVFTGFVGLVIERAVIRYLYGRPLETLLATWGVS LILQQAVRSIFGPTNREVRNPTWMSGVFDLGGLSITWNRLWIIVFSMVVFVALLLLLKRS AFGLQMRAVTQNRRMASSMGIRTGWVDAFTFALGSGIAGIAGVALSQIDNVSPNLGQSYI IDSFMVVVFGGVGNLWGTLVGALSLGVVNKFLEPFAGAVLGKILVLVLIILFIQKRPRGL FALKGRAVEA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server